{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:27:13Z","timestamp":1791354433395,"version":"4.3.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11030-024-10821-z","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T15:02:26Z","timestamp":1711119746000},"page":"4381-4401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Identification of novel potential cathepsin-B inhibitors through pharmacophore-based virtual screening, molecular docking, and dynamics simulation studies for the treatment of Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"28","author":[{"given":"Jatin","family":"Jangra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh Gajanan","family":"Bajad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,22]]},"reference":[{"key":"10821_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-016-0175-0","volume":"8","author":"J Cummings","year":"2016","unstructured":"Cummings J et al (2016) Drug development in Alzheimer\u2019s disease: the path to 2025. Alzheimer\u2019s Res Therap 8:1\u201312","journal-title":"Alzheimer\u2019s Res Therap"},{"issue":"9","key":"10821_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.disamonth.2010.06.001","volume":"56","author":"RJ Castellani","year":"2010","unstructured":"Castellani RJ, Rolston RK, Smith MA (2010) Alzheimer disease. Disease-a-Month: DM 56(9):484","journal-title":"Disease-a-Month: DM"},{"issue":"3","key":"10821_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.4103\/1673-5374.320970","volume":"17","author":"Y Ju","year":"2022","unstructured":"Ju Y, Tam KY (2022) Pathological mechanisms and therapeutic strategies for Alzheimer\u2019s disease. Neural Regen Res 17(3):543","journal-title":"Neural Regen Res"},{"issue":"10","key":"10821_CR4","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1002\/acn3.51197","volume":"7","author":"W Zhang","year":"2020","unstructured":"Zhang W et al (2020) Association of rare variants in neurodegenerative genes with familial Alzheimer\u2019s disease. Ann Clin Transl Neurol 7(10):1985\u20131995","journal-title":"Ann Clin Transl Neurol"},{"key":"10821_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-3311-3","volume-title":"Computational modeling of drugs against Alzheimer\u2019s disease","author":"K Roy","year":"2023","unstructured":"Roy K (2023) Computational modeling of drugs against Alzheimer\u2019s disease, vol 203. Springer"},{"key":"10821_CR6","doi-asserted-by":"publisher","first-page":"113320","DOI":"10.1016\/j.ejmech.2021.113320","volume":"216","author":"S Srivastava","year":"2021","unstructured":"Srivastava S, Ahmad R, Khare SK (2021) Alzheimer\u2019s disease and its treatment by different approaches: a review. Eur J Med Chem 216:113320","journal-title":"Eur J Med Chem"},{"issue":"13","key":"10821_CR7","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1093\/nar\/gkg563","volume":"31","author":"E Gasteiger","year":"2003","unstructured":"Gasteiger E et al (2003) ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 31(13):3784\u20133788","journal-title":"Nucleic Acids Res"},{"key":"10821_CR8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.biopha.2018.05.148","volume":"105","author":"S Patel","year":"2018","unstructured":"Patel S et al (2018) Cathepsins: Proteases that are vital for survival but can also be fatal. Biomed Pharmacother 105:526\u2013532","journal-title":"Biomed Pharmacother"},{"key":"10821_CR9","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s12035-013-8576-6","volume":"49","author":"A Pi\u0161lar","year":"2014","unstructured":"Pi\u0161lar A, Kos J (2014) Cysteine cathepsins in neurological disorders. Mol Neurobiol 49:1017\u20131030","journal-title":"Mol Neurobiol"},{"issue":"15","key":"10821_CR10","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.2174\/1389557522666220214095859","volume":"22","author":"A Sharma","year":"2022","unstructured":"Sharma A et al (2022) Cathepsin BA neuronal death mediator in Alzheimer\u2019s disease leading to neurodegeneration. Mini Rev Med Chem 22(15):2012\u20132023","journal-title":"Mini Rev Med Chem"},{"issue":"13","key":"10821_CR11","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","volume":"20","author":"N Kelley","year":"2019","unstructured":"Kelley N et al (2019) The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci 20(13):3328","journal-title":"Int J Mol Sci"},{"key":"10821_CR12","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1007\/s00018-012-1140-0","volume":"69","author":"I Hafner-Bratkovi\u010d","year":"2012","unstructured":"Hafner-Bratkovi\u010d I et al (2012) NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1\u03b2 and neuronal toxicity. Cell Mol Life Sci 69:4215\u20134228","journal-title":"Cell Mol Life Sci"},{"key":"10821_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.abb.2019.02.015","volume":"670","author":"RI Campden","year":"2019","unstructured":"Campden RI, Zhang Y (2019) The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation. Arch Biochem Biophys 670:32\u201342","journal-title":"Arch Biochem Biophys"},{"issue":"9","key":"10821_CR14","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0968-0896(97)00105-3","volume":"5","author":"N Schaschke","year":"1997","unstructured":"Schaschke N et al (1997) E-64 analogues as inhibitors of cathepsin B: on the role of the absolute configuration of the epoxysuccinyl group. Bioorg Med Chem 5(9):1789\u20131797","journal-title":"Bioorg Med Chem"},{"issue":"8","key":"10821_CR15","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.3390\/cells10081946","volume":"10","author":"N Chitranshi","year":"2021","unstructured":"Chitranshi N et al (2021) Identification of novel cathepsin B inhibitors with implications in Alzheimer\u2019s disease: computational refining and biochemical evaluation. Cells 10(8):1946","journal-title":"Cells"},{"issue":"8","key":"10821_CR16","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jmgm.2010.01.009","volume":"28","author":"Z Zhou","year":"2010","unstructured":"Zhou Z, Wang Y, Bryant SH (2010) QSAR models for predicting cathepsin B inhibition by small molecules\u2014continuous and binary QSAR models to classify cathepsin B inhibition activities of small molecules. J Mol Graph Model 28(8):714\u2013727","journal-title":"J Mol Graph Model"},{"issue":"26","key":"10821_CR17","doi-asserted-by":"publisher","first-page":"4524","DOI":"10.1021\/jm010206q","volume":"44","author":"PD Greenspan","year":"2001","unstructured":"Greenspan PD et al (2001) Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design. J Med Chem 44(26):4524\u20134534","journal-title":"J Med Chem"},{"issue":"9","key":"10821_CR18","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/cmdc.201000109","volume":"5","author":"L Mendieta","year":"2010","unstructured":"Mendieta L et al (2010) Novel peptidyl aryl vinyl sulfones as highly potent and selective inhibitors of cathepsins L and B. ChemMedChem 5(9):1556\u20131567","journal-title":"ChemMedChem"},{"issue":"3\u20134","key":"10821_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/1098-2299(200007\/08)50:3\/4<425::AID-DDR25>3.0.CO;2-B","volume":"50","author":"A Albeck","year":"2000","unstructured":"Albeck A (2000) Peptidyl epoxides as selective protease inactivators. Drug Dev Res 50(3\u20134):425\u2013434","journal-title":"Drug Dev Res"},{"issue":"2","key":"10821_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0003-2697(85)90598-6","volume":"149","author":"D Rasnick","year":"1985","unstructured":"Rasnick D (1985) Synthesis of peptide fluoromethyl ketones and the inhibition of human cathepsin B. Anal Biochem 149(2):461\u2013465","journal-title":"Anal Biochem"},{"issue":"2","key":"10821_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1021\/jm301544x","volume":"56","author":"I Sosi\u010d","year":"2013","unstructured":"Sosi\u010d I et al (2013) Development of new cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure\u2013activity relationships of nitroxoline derivatives. J Med Chem 56(2):521\u2013533","journal-title":"J Med Chem"},{"issue":"4","key":"10821_CR22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1021\/acs.biochem.1c00684","volume":"61","author":"MC Yoon","year":"2022","unstructured":"Yoon MC et al (2022) Molecular features of CA-074 pH-dependent inhibition of cathepsin B. Biochemistry 61(4):228\u2013238","journal-title":"Biochemistry"},{"issue":"20","key":"10821_CR23","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1016\/j.bmc.2005.05.071","volume":"13","author":"X Pan","year":"2005","unstructured":"Pan X et al (2005) Amentoflavone and its derivatives as novel natural inhibitors of human cathepsin B. Bioorg Med Chem 13(20):5819\u20135825","journal-title":"Bioorg Med Chem"},{"key":"10821_CR24","doi-asserted-by":"publisher","first-page":"113705","DOI":"10.1016\/j.ejmech.2021.113705","volume":"224","author":"VT Sabe","year":"2021","unstructured":"Sabe VT et al (2021) Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review. Eur J Med Chem 224:113705","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10821_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2174\/138920307781369427","volume":"8","author":"AS Reddy","year":"2007","unstructured":"Reddy AS et al (2007) Virtual screening in drug discovery\u2014a computational perspective. Curr Protein Pept Sci 8(4):329\u2013351","journal-title":"Curr Protein Pept Sci"},{"issue":"11\u201312","key":"10821_CR26","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.drudis.2010.03.013","volume":"15","author":"S-Y Yang","year":"2010","unstructured":"Yang S-Y (2010) Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discovery Today 15(11\u201312):444\u2013450","journal-title":"Drug Discovery Today"},{"issue":"4","key":"10821_CR27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/oxfordjournals.jbchem.a022651","volume":"127","author":"A Yamamoto","year":"2000","unstructured":"Yamamoto A et al (2000) Substrate specificity of bovine cathepsin B and its inhibition by CA074, based on crystal structure refinement of the complex. J Biochem 127(4):635\u2013643","journal-title":"J Biochem"},{"issue":"W1","key":"10821_CR28","doi-asserted-by":"publisher","first-page":"W442","DOI":"10.1093\/nar\/gkw287","volume":"44","author":"J Sunseri","year":"2016","unstructured":"Sunseri J, Koes DR (2016) Pharmit: interactive exploration of chemical space. Nucleic Acids Res 44(W1):W442\u2013W448","journal-title":"Nucleic Acids Res"},{"key":"10821_CR29","doi-asserted-by":"publisher","first-page":"100135","DOI":"10.1016\/j.medidd.2022.100135","volume":"15","author":"S Kchouk","year":"2022","unstructured":"Kchouk S, Hegazy L (2022) Pharmacophore modeling for biological targets with high flexibility: LXR\u03b2 case study. Med Drug Discov 15:100135","journal-title":"Med Drug Discov"},{"issue":"16","key":"10821_CR30","doi-asserted-by":"publisher","first-page":"4956","DOI":"10.1080\/07391102.2019.1691659","volume":"38","author":"S Bhagwati","year":"2020","unstructured":"Bhagwati S, Siddiqi MI (2020) Identification of potential soluble epoxide hydrolase (sEH) inhibitors by ligand-based pharmacophore model and biological evaluation. J Biomol Struct Dyn 38(16):4956\u20134966","journal-title":"J Biomol Struct Dyn"},{"issue":"14","key":"10821_CR31","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM et al (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55(14):6582\u20136594","journal-title":"J Med Chem"},{"issue":"1","key":"10821_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-015-0068-4","volume":"7","author":"SR Heller","year":"2015","unstructured":"Heller SR et al (2015) InChI, the IUPAC international chemical identifier. J Cheminf 7(1):1\u201334","journal-title":"J Cheminf"},{"issue":"1","key":"10821_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-3-1","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM et al (2011) Open Babel: an open chemical toolbox. J Cheminf 3(1):1\u201314","journal-title":"J Cheminf"},{"issue":"2","key":"10821_CR34","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1021\/acs.jmedchem.5b00361","volume":"59","author":"M Pouliot","year":"2016","unstructured":"Pouliot M, Jeanmart S (2016) Pan assay interference compounds (PAINS) and other promiscuous compounds in antifungal research. J Med Chem 59(2):497\u2013503","journal-title":"J Med Chem"},{"issue":"1","key":"10821_CR35","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7(1):42717","journal-title":"Sci Rep"},{"issue":"1","key":"10821_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1145\/1656274.1656280","volume":"11","author":"MR Berthold","year":"2009","unstructured":"Berthold MR et al (2009) KNIME-the Konstanz information miner: version 2.0 and beyond. AcM SIGKDD Explor Newslett 11(1):26\u201331","journal-title":"AcM SIGKDD Explor Newslett"},{"key":"10821_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2015.01.009","volume":"86","author":"S Tian","year":"2015","unstructured":"Tian S et al (2015) The application of in silico drug-likeness predictions in pharmaceutical research. Adv Drug Deliv Rev 86:2\u201310","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10821_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/cn100008c","volume":"1","author":"TT Wager","year":"2010","unstructured":"Wager TT et al (2010) Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties. ACS Chem Neurosci 1(6):435\u2013449","journal-title":"ACS Chem Neurosci"},{"issue":"6","key":"10821_CR39","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/qsar.200290002","volume":"21","author":"M Ashton","year":"2002","unstructured":"Ashton M et al (2002) Identification of diverse database subsets using property-based and fragment-based molecular descriptions. Quant Struct-Act Relat 21(6):598\u2013604","journal-title":"Quant Struct-Act Relat"},{"issue":"5","key":"10821_CR40","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1046\/j.1460-9568.1998.00184.x","volume":"10","author":"T Yamashima","year":"1998","unstructured":"Yamashima T et al (1998) Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on \u2018calpain\u2013cathepsin hypothesis.\u2019 Eur J Neurosci 10(5):1723\u20131733","journal-title":"Eur J Neurosci"},{"issue":"8","key":"10821_CR41","doi-asserted-by":"publisher","first-page":"140428","DOI":"10.1016\/j.bbapap.2020.140428","volume":"1868","author":"V Hook","year":"2020","unstructured":"Hook V et al (2020) Cathepsin B in neurodegeneration of Alzheimer\u2019s disease, traumatic brain injury, and related brain disorders. Biochim Biophys Acta 1868(8):140428","journal-title":"Biochim Biophys Acta"},{"issue":"13","key":"10821_CR42","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF et al (2004) UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605\u20131612","journal-title":"J Comput Chem"},{"issue":"3","key":"10821_CR43","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/prot.340230306","volume":"23","author":"A \u0160ali","year":"1995","unstructured":"\u0160ali A et al (1995) Evaluation of comparative protein modeling by MODELLER. Proteins: Struct Funct Bioinf 23(3):318\u2013326","journal-title":"Proteins: Struct Funct Bioinf"},{"key":"10821_CR44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/978-1-4613-1571-1_7","volume-title":"Prediction of protein structure and the principles of protein conformation","author":"D Mackay","year":"1989","unstructured":"Mackay D, Cross A, Hagler A (1989) The role of energy minimization in simulation strategies of biomolecular systems. Prediction of protein structure and the principles of protein conformation. Springer, pp 317\u2013358"},{"issue":"2","key":"10821_CR45","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1021\/ci800293n","volume":"49","author":"KE Hevener","year":"2009","unstructured":"Hevener KE et al (2009) Validation of molecular docking programs for virtual screening against dihydropteroate synthase. J Chem Inf Model 49(2):444\u2013460","journal-title":"J Chem Inf Model"},{"issue":"1","key":"10821_CR46","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/ph12010036","volume":"12","author":"VDS Pinto","year":"2019","unstructured":"Pinto VDS et al (2019) In silico study to identify new antituberculosis molecules from natural sources by hierarchical virtual screening and molecular dynamics simulations. Pharmaceuticals 12(1):36","journal-title":"Pharmaceuticals"},{"issue":"W1","key":"10821_CR47","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong G et al (2021) ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res 49(W1):W5\u2013W14","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10821_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/pr9010071","volume":"9","author":"OM Salo-Ahen","year":"2020","unstructured":"Salo-Ahen OM et al (2020) Molecular dynamics simulations in drug discovery and pharmaceutical development. Processes 9(1):71","journal-title":"Processes"},{"issue":"1","key":"10821_CR49","doi-asserted-by":"publisher","first-page":"34984","DOI":"10.1038\/srep34984","volume":"6","author":"I Aier","year":"2016","unstructured":"Aier I, Varadwaj PK, Raj U (2016) Structural insights into conformational stability of both wild-type and mutant EZH2 receptor. Sci Rep 6(1):34984","journal-title":"Sci Rep"},{"issue":"18","key":"10821_CR50","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.3390\/molecules24183387","volume":"24","author":"NN Cob-Calan","year":"2019","unstructured":"Cob-Calan NN et al (2019) Molecular docking and dynamics simulation of protein \u03b2-tubulin and antifungal cyclic lipopeptides. Molecules 24(18):3387","journal-title":"Molecules"},{"issue":"8","key":"10821_CR51","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1080\/07391102.2020.1848630","volume":"40","author":"N Tripathi","year":"2022","unstructured":"Tripathi N et al (2022) Virtual screening and molecular simulation study of natural products database for lead identification of novel coronavirus main protease inhibitors. J Biomol Struct Dyn 40(8):3655\u20133667","journal-title":"J Biomol Struct Dyn"},{"key":"10821_CR52","doi-asserted-by":"publisher","first-page":"118901","DOI":"10.1016\/j.molliq.2022.118901","volume":"354","author":"S Ghahremanian","year":"2022","unstructured":"Ghahremanian S et al (2022) Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: a structural review. J Mol Liq 354:118901","journal-title":"J Mol Liq"},{"issue":"12","key":"10821_CR53","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1002\/ptr.6868","volume":"34","author":"PK Parida","year":"2020","unstructured":"Parida PK, Paul D, Chakravorty D (2020) The natural way forward: molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of SARS-CoV-2 targets. Phytother Res 34(12):3420\u20133433","journal-title":"Phytother Res"},{"issue":"2","key":"10821_CR54","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/polym11020282","volume":"11","author":"Z Jiang","year":"2019","unstructured":"Jiang Z et al (2019) Effects of an electric field on the conformational transition of the protein: a molecular dynamics simulation study. Polymers 11(2):282","journal-title":"Polymers"},{"issue":"5","key":"10821_CR55","doi-asserted-by":"publisher","first-page":"456","DOI":"10.2174\/1389203715666140327114232","volume":"15","author":"S Ausaf Ali","year":"2014","unstructured":"Ausaf Ali S et al (2014) A review of methods available to estimate solvent-accessible surface areas of soluble proteins in the folded and unfolded states. Curr Protein Pept Sci 15(5):456\u2013476","journal-title":"Curr Protein Pept Sci"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10821-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-10821-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10821-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T17:07:27Z","timestamp":1734628047000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-10821-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10821"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-10821-z","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,22]]},"assertion":[{"value":"28 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}